Here at Colon and Rectal Surgery Associates, we pride ourselves on being on the forefront of technology and patient care. We have participated on past research projects working on reducing surgical infection and post operative nausea. With that in mind, we are starting three new research projects in 2018.
The first project will be looking at IV Meloxicam to decrease post-operative pain. This medication is an anti-inflammatory that is administered during and after surgery to reduce pain and inflammation during recovery from abdominal surgery. This project is planned to start in January 2018
The second project will be looking at Crohn’s patients with anal fistulas. For patients that qualify with multiple anal fistula from their Crohn’s disease, adipose (fat) derived stem cells will be inserted into the fistula tracts in an attempt to get them to heal. This project is planned to start in the first quarter of 2018.
The third project will for patients who have or have a history of colon or rectal cancer. The standard blood test for monitoring recurrence is called a CEA test. This will be compared with a new blood test called Colvera, which looks a pieces of DNA found in the blood, to screen for cancer.